Psychometric assessment of the Cardiac Depression Scale Short Form in cardiac outpatients

Hare, David L.; Selvadurai, Louisa P.; Wang, Jerry Q; Yau, Ho Hin; Stone, Madeline J; Raman, Bhairavi; Wu, Nibo; Shi, William Y.; Toukhsati, Samia Rachael

doi:10.1177/1474515116652759

Cited by 8 publications

(5 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Secondary outcomes included patient compliance with weight monitoring based on a per-protocol analysis (only undertaken in participants who completed the trial) and an analysis of other guideline recommendations assessed by the Heart Failure Compliance Questionnaire [ 12 ], health-related quality of life (five-dimension EuroQol, EQ-5D [ 16 ]), 6-min walk test distance [ 17 ], psychological state (cardiac depression scale short form 2 [ 18 ]), frailty (clinical frailty index [ 19 ]), and clinical outcomes of CHF-related and all-cause hospitalizations and ED presentations. CHF-related events were determined by using the International Classification of Diseases, Tenth Revision, Clinical Modification, diagnosis codes ( Multimedia Appendix 3 ) [ 20 ].…”

Section: Methodsmentioning

confidence: 99%

The Effects of Telemonitoring on Patient Compliance With Self-Management Recommendations and Outcomes of the Innovative Telemonitoring Enhanced Care Program for Chronic Heart Failure: Randomized Controlled Trial

Ding¹,

Jayasena²,

Chen³

et al. 2020

J Med Internet Res

View full text Add to dashboard Cite

Background Telemonitoring enables care providers to remotely support outpatients in self-managing chronic heart failure (CHF), but the objective assessment of patient compliance with self-management recommendations has seldom been studied. Objective This study aimed to evaluate patient compliance with self-management recommendations of an innovative telemonitoring enhanced care program for CHF (ITEC-CHF). Methods We conducted a multicenter randomized controlled trial with a 6-month follow-up. The ITEC-CHF program comprised the provision of Bluetooth-enabled scales linked to a call center and nurse care services to assist participants with weight monitoring compliance. Compliance was defined a priori as weighing at least 4 days per week, analyzed objectively from weight recordings on the scales. The intention-to-treat principle was used to perform the analysis. Results A total of 184 participants (141/184, 76.6% male), with a mean age of 70.1 (SD 12.3) years, were randomized to receive either ITEC-CHF (n=91) or usual care (control; n=93), of which 67 ITEC-CHF and 81 control participants completed the intervention. For the compliance criterion of weighing at least 4 days per week, the proportion of compliant participants in the ITEC-CHF group was not significantly higher than that in the control group (ITEC-CHF: 67/91, 74% vs control: 56/91, 60%; P=.06). However, the proportion of ITEC-CHF participants achieving the stricter compliance standard of at least 6 days a week was significantly higher than that in the control group (ITEC-CHF: 41/91, 45% vs control: 23/93, 25%; P=.005). Conclusions ITEC-CHF improved participant compliance with weight monitoring, although the withdrawal rate was high. Telemonitoring is a promising method for supporting both patients and clinicians in the management of CHF. However, further refinements are required to optimize this model of care. Trial Registration Australian New Zealand Clinical Trial Registry ACTRN12614000916640; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=366691

show abstract

Section: Methodsmentioning

confidence: 99%

The Effects of Telemonitoring on Patient Compliance With Self-Management Recommendations and Outcomes of the Innovative Telemonitoring Enhanced Care Program for Chronic Heart Failure: Randomized Controlled Trial

Ding¹,

Jayasena²,

Chen³

et al. 2020

J Med Internet Res

View full text Add to dashboard Cite

show abstract

“…The rate of compliant days with weight monitoring (days with at least one body weight entry) per week for each participant during his/her trial period will also be computed, and the histogram of the rate will be analysed. The secondary outcomes will include compliance with other guideline recommendations assessed by Heart Failure Compliance Questionnaire 32 (health maintenance, medication, diet and exercise), health outcomes including HQoL (European Quality of Life Five Dimension, EQ-5D 33 ), risk factors, functional capacity (6 min walk test 34 ), psychological states (Cardiac Depression Scale, CDS-SF2 35 ) and frailty scale (Canadian Frailty Index 36 ), and health economic outcomes related to the use of healthcare resources such as hospital readmissions and GP/ED visits. Patients’ characteristics and assessment records will be collected by the project nurses.…”

Section: Methodsmentioning

confidence: 99%

Innovative Telemonitoring Enhanced Care Programme for Chronic Heart Failure (ITEC-CHF) to improve guideline compliance and collaborative care: protocol of a multicentre randomised controlled trial

Ding

Jayasena

Maiorana³

et al. 2017

BMJ Open

View full text Add to dashboard Cite

IntroductionChronic heart failure (CHF) is a life-threatening chronic disease characterised by periodic exacerbations and recurrent hospitalisations. In the management of CHF, patient compliance with evidence-based clinical guidelines is essential, but remains difficult practically. The objective of this study is to examine whether an Innovative Telemonitoring Enhanced Care Programme for CHF (ITEC-CHF) improves patients’ compliance, and associated health and economic outcomes.Methods and analysisAn open multicentre randomised controlled trial has been designed. Patients will be recruited and randomised to receive either ITEC-CHF (n=150) or usual care CHF (n=150) for at least 6 months. ITEC-CHF combines usual care and an additional telemonitoring service including remote weight monitoring, structured telephone support and nurse-led collaborative care. The primary outcomes are the compliance rates with the best-practice guidelines for daily weight monitoring. The secondary outcomes include the compliance with other guideline recommendations (health maintenance, medication, diet and exercise), health (health-related quality of life, risk factors, functional capacity and psychological states) and economic outcomes related to the use of healthcare resources such as hospital readmissions and general practitioner/emergency department visits.Ethics and disseminationThe clinical trial has been approved by Peninsula Health Human Research Ethics Committee (HREC Reference: HREC/14/PH/27), Royal Perth Hospital Human Research Ethics Committee (Reference: 15-081) and the Curtin University Human Research Ethics Committee (Reference: HR 181/2014). We will disseminate the final results to the public via conferences and journal publications. A final study report will also be provided to the ethics committees.Trial registration numberRegistered with Australian New Zealand Clinical Trial Registry (ACTRN12614000916640).

show abstract

“…An example is the five-item ‘short form’ of the CDS, the CDS-SF, designed to screen for MDD in CVD patients, completion taking less than one minute of the patient's time [16] ([Fig. 1].…”

Section: Detection Of Depressionmentioning

confidence: 99%

“…Screening and management of depression in CVD patients are extremely important and a management algorithm starting with the PHQ-2 has been suggested [15 & ]. An example is the five-item 'short form' of the CDS, the CDS-SF, designed to screen for MDD in CVD patients, completion taking less than one minute of the patient's time [16] ([Fig. 1].…”

Section: Detection Of Depressionmentioning

confidence: 99%

Depression and cardiovascular disease

Hare

2021

Current Opinion in Lipidology

View full text Add to dashboard Cite

Purpose of review The purpose of this review is to outline the relationship between cardiovascular disease (CVD) and depression, both as a cause of and a result of CVD. Recent findings The prevalence of depression seems to be increasing in the general population. It is likely that depression will be even more of a problem for CVD patients in the post-COVID-19 pandemic era. New studies confirm the independent association of depression with later incident CVD, although perhaps not as strong as suggested by some previous studies. Depression seems to be becoming even more prevalent in CVD patients, with new data for stroke and peripheral arterial disease patients. Cardiologists rarely screen for depression and most do not believe that they have a responsibility for detecting or treating depression. There are new data suggesting that patients who are more in control of their lives have better outcomes and that change is possible. Summary Depression is preventable and treatable. It is imperative to detect and manage depression in CVD patients. Additional research is required to see whether or not comprehensive patient screening for depression translates into both better quality of life and improved clinical outcomes.

show abstract

Psychometric assessment of the Cardiac Depression Scale Short Form in cardiac outpatients

Abstract: These findings confirm the excellent psychometric properties of the DS-SF2 as an ideal tool for screening depression in cardiac patients in clinical practice. The DS-SF2 should be regarded as the definitive version of the DS-SF.

Cited by 8 publications

References 35 publications

The Effects of Telemonitoring on Patient Compliance With Self-Management Recommendations and Outcomes of the Innovative Telemonitoring Enhanced Care Program for Chronic Heart Failure: Randomized Controlled Trial

The Effects of Telemonitoring on Patient Compliance With Self-Management Recommendations and Outcomes of the Innovative Telemonitoring Enhanced Care Program for Chronic Heart Failure: Randomized Controlled Trial

Innovative Telemonitoring Enhanced Care Programme for Chronic Heart Failure (ITEC-CHF) to improve guideline compliance and collaborative care: protocol of a multicentre randomised controlled trial

Depression and cardiovascular disease

Contact Info

Product

Resources

About